SILVERARC CAPITAL MANAGEMENT, LLC
CIK 1816307 · View on SEC EDGAR ↗
- Portfolio value
- $962.2M
- Positions
- 73
- As of
- June 30, 2026
#2,521 of 9,443 by 13F value · top 26.7%
Portfolio value QoQ: -1.8% 13F does not disclose cash
- Top 10 holdings weight
- 42.32%
- Top 25 holdings weight
- 72.33%
- Positions above 1%
- 33
- Effective number of positions
- 36.4
Based on 13F long-equity holdings only (cash, bonds, shorts not disclosed)
Turnover Q2 2026: 36.39% Est. buys $353,312,711 · sells $378,351,109
Median holding: 2.0 quarters Tracked Q4 2024–Q2 2026 · 39.5% still held
- New positions
- 26
- Increased
- 17
- Decreased
- 27
- Closed
- 21
Put-notional exposure: 2.7% puts 13F reports option positions at underlying notional value — may include hedges, not necessarily bearish bets
On this page
- Performance vs S&P How this manager's 13F portfolio performed against the S&P 500.
- Sector breakdown How the portfolio splits across market sectors.
- Portfolio Every stock this institution reports holding, from its latest 13F.
- High-conviction bets The holdings this manager is most concentrated in.
- Biggest new bets Brand-new positions opened in the latest quarter.
- Top moves The biggest position increases and decreases this quarter.
- Exited positions Positions the manager fully sold out of last quarter.
Performance vs S&P 500
Annualized: +68.3% · S&P 500: +18.0%
Approximates a buy-and-hold portfolio built from quarterly SEC 13F snapshots. Excludes cash, short positions, options/derivatives, and non-13(f) securities — reflects the disclosed long-equity book only, not total fund AUM. SEC filing lag is up to 45 days; this is not a real-time-copyable timing.
Priceable coverage: 95.9% · Options excluded: 7.3%
Sector breakdown
Healthcare
82.9%
Other/Unmapped
17.1%
Full portfolio 73 positions
| Type | Streak | 8Q trend | |||||
|---|---|---|---|---|---|---|---|
| Unknown issuer (CUSIP: K08588103) | $55,006,732 | 5.72% | 206,234 | Up ×1 | |||
| CELC Celcuity Inc. - Common Stock | $52,414,202 | 5.45% | 500,996 | $11,563,154 | Up ×1 | ||
| COGT Cogent Biosciences, Inc. - Common Stock | $49,563,361 | 5.15% | 1,280,707 | $-1,019,774 | Down ×1 | ||
| URGN UroGen Pharma Ltd. - Ordinary Shares | $47,912,827 | 4.98% | 1,301,979 | $20,888,078 | Down ×2 | ||
| IMNM Immunome, Inc. - Common Stock | $42,740,421 | 4.44% | 2,017,009 | $2,274,841 | Up ×2 | ||
| DNTH Dianthus Therapeutics, Inc. - Common Stock | $38,017,200 | 3.95% | 390,000 | $-16,929,084 | Down ×2 | ||
| RYTM Rhythm Pharmaceuticals, Inc. - Common Stock | $34,581,515 | 3.59% | 311,461 | $7,968,695 | Up ×2 | ||
| ORKA Oruka Therapeutics, Inc. - Common Stock | $33,576,166 | 3.49% | 352,802 | $26,174,129 | Up ×1 | ||
| GLUE Monte Rosa Therapeutics, Inc. - Common Stock | $26,820,739 | 2.79% | 1,108,295 | $-6,112,819 | Down ×1 | ||
| SNDX Syndax Pharmaceuticals, Inc. - Common Stock | $26,546,565 | 2.76% | 1,214,390 | $5,779,829 | Up ×4 | ||
| ELVN Enliven Therapeutics, Inc. - Common Stock | $24,836,137 | 2.58% | 489,382 | ||||
| IMVT Immunovant, Inc. - Common Stock | $23,853,769 | 2.48% | 619,096 | $13,564,147 | Up ×1 | ||
| ERAS Erasca, Inc. - Common Stock | $23,138,636 | 2.40% | 1,263,026 | $-6,823,682 | Down ×1 | ||
| SGMT Sagimet Biosciences Inc. - Series A Common Stock | $22,631,106 | 2.35% | 2,927,698 | ||||
| ABVX Abivax SA - American Depositary Shares | $22,599,963 | 2.35% | 169,593 | $-11,086,753 | Down ×3 | ||
| PRAX Praxis Precision Medicines, Inc. - Common Stock | $21,988,672 | 2.29% | 65,679 | $-1,064,667 | Down ×2 | ||
| KOD Kodiak Sciences Inc - Common Stock | $21,282,134 | 2.21% | 546,256 | $-16,530,238 | Down ×2 | ||
| Unknown issuer (CUSIP: 00214Q952) | $21,030,000 | 2.19% | 500,000 | Put option | Up ×1 | ||
| DFTX Definium Therapeutics, Inc. - Common Shares | $18,816,000 | 1.96% | 400,000 | Up ×1 | |||
| VCYT Veracyte, Inc. - Common Stock | $18,676,199 | 1.94% | 318,001 | $12,888,062 | Up ×1 | ||
| Unknown issuer (CUSIP: 87164F905) | $15,162,096 | 1.58% | 693,600 | Call option | $7,686,896 | Up ×1 | |
| GH Guardant Health, Inc. - Common Stock | $14,976,895 | 1.56% | 99,826 | $5,877,157 | Up ×2 | ||
| CCCC C4 Therapeutics, Inc. - Common Stock | $14,159,720 | 1.47% | 3,032,060 | $9,131,725 | Up ×1 | ||
| ZBIO Zenas BioPharma, Inc. - Common Stock | $12,938,445 | 1.34% | 509,789 | $-9,269,084 | Down ×1 | ||
| TRVI Trevi Therapeutics, Inc. - Common Stock | $12,646,472 | 1.31% | 678,095 | $6,548,727 | Up ×1 | ||
| HLXC Helix Acquisition Corp. III - Class A Ordinary Shares | $12,532,015 | 1.30% | 1,177,821 | $248,717 | Down ×1 | ||
| ALXO ALX Oncology Holdings Inc. - Common Stock | $11,891,647 | 1.24% | 5,744,757 | Up ×1 | |||
| MANE Veradermics, Incorporated Common Stock | $11,679,300 | 1.21% | 95,000 | Up ×1 | |||
| XENE Xenon Pharmaceuticals Inc. - Common Shares | $11,276,516 | 1.17% | 186,821 | $-223,170 | Down ×1 | ||
| Unknown issuer (CUSIP: 05348Y105) | $10,879,632 | 1.13% | 330,487 | Up ×1 | |||
| BIIB Biogen Inc. - Common Stock | $10,392,702 | 1.08% | 48,101 | $1,048,922 | Down ×3 | ||
| ACRS Aclaris Therapeutics, Inc. - Common Stock | $10,296,890 | 1.07% | 1,946,482 | Up ×1 | |||
| CERS Cerus Corporation - Common Stock | $10,140,392 | 1.05% | 3,472,737 | $4,359,076 | Up ×6 | ||
| AVTX Avalo Therapeutics, Inc. - Common Stock | $9,247,429 | 0.96% | 500,402 | ||||
| BNTC Benitec Biopharma Inc. - Common Stock | $9,096,072 | 0.95% | 679,826 | $1,452,301 | Down ×2 | ||
| PCVX Vaxcyte, Inc. - Common Stock | $8,428,850 | 0.88% | 145,000 | $4,004 | Up ×1 | ||
| WGS GeneDx Holdings Corp. - Class A Common Stock | $8,393,767 | 0.87% | 122,269 | Up ×1 | |||
| SVRA Savara, Inc. - Common Stock | $8,349,627 | 0.87% | 1,355,459 | $536,465 | Down ×1 | ||
| OVID Ovid Therapeutics Inc. - Common Stock | $8,342,037 | 0.87% | 3,101,129 | $6,122,037 | Up ×1 | ||
| ORIC Oric Pharmaceuticals, Inc. - Common Stock | $8,001,995 | 0.83% | 738,873 | $-5,935,132 | Down ×3 | ||
| Unknown issuer (CUSIP: 68622P909) | $7,392,558 | 0.77% | 682,600 | Call option | Up ×1 | ||
| Unknown issuer (CUSIP: 61225M902) | $7,260,000 | 0.75% | 300,000 | Call option | Up ×1 | ||
| CMPS COMPASS Pathways Plc - American Depository Shares | $7,122,855 | 0.74% | 503,382 | $5,463,855 | Up ×1 | ||
| CGEN Compugen Ltd. - Ordinary Shares | $6,814,310 | 0.71% | 3,184,257 | $-248,440 | Down ×2 | ||
| SLDB Solid Biosciences Inc. - Common Stock | $6,677,816 | 0.69% | 668,450 | ||||
| Unknown issuer (CUSIP: 00370M903) | $6,663,000 | 0.69% | 50,000 | Call option | Up ×1 | ||
| IBIO iBio, Inc. - Common Stock | $6,160,858 | 0.64% | 3,520,490 | $5,731,458 | Up ×2 | ||
| IRON Disc Medicine, Inc. - Common Stock | $6,055,992 | 0.63% | 82,800 | $-6,478,038 | Down ×1 | ||
| ALKS Alkermes plc - Ordinary Shares | $5,946,518 | 0.62% | 113,494 | $-10,330,185 | Down ×1 | ||
| SYRE Spyre Therapeutics, Inc. - Common Stock | $5,323,160 | 0.55% | 59,959 | $-4,089,852 | Down ×2 | ||
| ARTV Artiva Biotherapeutics, Inc. - Common Stock | $5,092,500 | 0.53% | 525,000 | Up ×1 | |||
| CTNM Contineum Therapeutics, Inc. - Common stock | $4,853,653 | 0.50% | 296,135 | $913,072 | Down ×2 | ||
| QURE uniQure N.V. - Ordinary Shares | $4,836,300 | 0.50% | 105,000 | ||||
| Unknown issuer (CUSIP: G75226103) | $3,852,000 | 0.40% | 360,000 | Up ×1 | |||
| ABEO Abeona Therapeutics Inc. - Common Stock | $3,772,315 | 0.39% | 610,407 | $865,055 | Down ×1 | ||
| INSM Insmed Incorporated - Common Stock | $3,671,780 | 0.38% | 34,438 | $-2,190,412 | Down ×6 | ||
| KPTI Karyopharm Therapeutics Inc. - Common Stock | $2,906,184 | 0.30% | 297,460 | Up ×1 | |||
| Unknown issuer (CUSIP: 501575954) | $2,866,750 | 0.30% | 25,000 | Put option | Up ×1 | ||
| CAMP CAMP4 Therapeutics Corporation - Common Stock | $2,856,206 | 0.30% | 653,594 | $-26,144 | |||
| ELUT Elutia, Inc. - Class A Common Stock | $2,148,243 | 0.22% | 2,192,980 | $-474,678 | Down ×3 | ||
| RVMD Revolution Medicines, Inc. - Common Stock | $1,872,800 | 0.19% | 10,000 | Up ×1 | |||
| SION Sionna Therapeutics, Inc. - Common Stock | $1,868,607 | 0.19% | 42,478 | $288,379 | Up ×1 | ||
| Unknown issuer (CUSIP: 00091E959) | $1,826,584 | 0.19% | 157,600 | Put option | Up ×1 | ||
| TELA TELA Bio, Inc. - Common stock | $1,602,901 | 0.17% | 2,137,201 | $202,128 | Down ×3 | ||
| ACHV Achieve Life Sciences, Inc. - Common Shares | $1,483,472 | 0.15% | 227,178 | Up ×1 | |||
| Unknown issuer (CUSIP: 359616909) | $1,434,354 | 0.15% | 391,900 | Call option | $-1,571,519 | ||
| GUTS Fractyl Health, Inc. - Common Stock | $1,301,208 | 0.14% | 1,637,976 | $522,204 | Down ×3 | ||
| CNTB Connect Biopharma Holdings Limited - Ordinary Shares | $1,297,100 | 0.13% | 545,000 | Up ×1 | |||
| CBIO Crescent Biopharma, Inc. - Common Stock | $1,063,872 | 0.11% | 59,104 | $-1,333,413 | Down ×1 | ||
| CLRB Cellectar Biosciences, Inc. - Common Stock | $894,404 | 0.09% | 321,728 | Up ×1 | |||
| FHTX Foghorn Therapeutics Inc. - Common Stock | $224,358 | 0.02% | 45,975 | Up ×1 | |||
| ADGM Adagio Medical Holdings, Inc - Common Stock | $146,193 | 0.02% | 224,360 | $-143,575 | Down ×2 | ||
| RCKTW Rocket Pharmaceuticals, Inc. - Warrant | $356 | 0.00% | 104,828 | $-1,803 | |||
| No matches | |||||||
Conviction holdings
Positions increased for 3+ consecutive quarters.
Share counts are as reported in 13F filings (not split-adjusted)
Biggest new bets
New positions opened this quarter, largest first.
| Security | Value | Shares | % of portfolio |
|---|---|---|---|
| Unknown issuer (CUSIP: K08588103) | $55,006,732 | 206,234 | 5.72% |
| ELVN | $24,836,137 | 489,382 | 2.58% |
| SGMT | $22,631,106 | 2,927,698 | 2.35% |
| Unknown issuer (CUSIP: 00214Q952) | $21,030,000 | 500,000 | 2.19% |
| DFTX | $18,816,000 | 400,000 | 1.96% |
| ALXO | $11,891,647 | 5,744,757 | 1.24% |
| MANE | $11,679,300 | 95,000 | 1.21% |
| Unknown issuer (CUSIP: 05348Y105) | $10,879,632 | 330,487 | 1.13% |
| ACRS | $10,296,890 | 1,946,482 | 1.07% |
| AVTX | $9,247,429 | 500,402 | 0.96% |
| WGS | $8,393,767 | 122,269 | 0.87% |
| Unknown issuer (CUSIP: 68622P909) | $7,392,558 | 682,600 | 0.77% |
| Unknown issuer (CUSIP: 61225M902) | $7,260,000 | 300,000 | 0.75% |
| SLDB | $6,677,816 | 668,450 | 0.69% |
| Unknown issuer (CUSIP: 00370M903) | $6,663,000 | 50,000 | 0.69% |
Top movers (QoQ)
| Security | Action | Shares Δ | Value Δ |
|---|---|---|---|
| ORKA | Bought more | +202K | +$26.2M |
| URGN | Trimmed | -201K | +$20.9M |
| DNTH | Trimmed | -265K | -$16.9M |
| KOD | Trimmed | -446K | -$16.5M |
| IMVT | Bought more | +205K | +$13.6M |
| VCYT | Bought more | +138K | +$12.9M |
| CELC | Bought more | +143K | +$11.6M |
| ABVX | Trimmed | -133K | -$11.1M |
| ALKS | Trimmed | -347K | -$10.3M |
| ZBIO | Trimmed | -626K | -$9.3M |
Exited positions
Includes corporate events (mergers, delistings) — not all exits are sells
Closed positions reflect 13F reporting changes; for index managers these are often mechanical (delisting, M&A, index rebalancing), not active decisions.
| Security | Quarter | Shares before | Value before | Price since exit |
|---|---|---|---|---|
| KALV | June 30, 2026 | 2,876,407 | $57,902,073 | No longer tracked |
| MRUS | Sept. 30, 2025 | 741,972 | $39,027,727 | No longer tracked |
| RNA | Dec. 31, 2025 | 844,633 | $36,800,660 | -81.1% |
| NUVL | June 30, 2026 | 354,914 | $36,360,939 | No longer tracked |
| VRNA | Sept. 30, 2025 | 358,297 | $33,887,730 | No longer tracked |
| AKRO | Dec. 31, 2025 | 643,636 | $30,559,837 | No longer tracked |
| ASND | June 30, 2026 | 124,658 | $28,513,024 | -2.8% |
| CDTX | Dec. 31, 2025 | 220,902 | $21,153,576 | No longer tracked |
| NBIX | Sept. 30, 2025 | 162,969 | $20,483,574 | 10.3% |
| ETNB | Sept. 30, 2025 | 2,037,087 | $20,004,194 | No longer tracked |
| CNTA | June 30, 2026 | 466,345 | $18,523,223 | No longer tracked |
| PLRX | March 31, 2025 | 1,315,601 | $17,326,465 | -13.3% |
| SLNO | Sept. 30, 2025 | 204,591 | $17,140,634 | No longer tracked |
| SRRK | June 30, 2026 | 339,613 | $16,695,375 | 0.7% |
| ITCI | March 31, 2025 | 179,085 | $14,957,179 | No longer tracked |
| IRON | June 30, 2025 | 236,471 | $11,738,420 | 49.9% |
| CYTK | Dec. 31, 2025 | 211,000 | $11,596,560 | 20.5% |
| CGON | June 30, 2026 | 166,349 | $11,258,500 | 11.1% |
| VRDN | March 31, 2026 | 348,569 | $10,847,467 | 23.5% |
| PFE | March 31, 2026 | 419,134 | $10,436,437 | -0.9% |
| PSTX | March 31, 2025 | 1,012,307 | $9,718,147 | No longer tracked |
| AVTX | March 31, 2026 | 524,436 | $9,523,758 | 35.8% |
| VSTM | Dec. 31, 2025 | 1,042,757 | $9,207,544 | -7.9% |
| SRRK | Dec. 31, 2025 | 233,920 | $8,711,181 | 25.8% |
| WVE | June 30, 2025 | 1,050,374 | $8,487,022 | -17.8% |
| PFE | Sept. 30, 2025 | 344,338 | $8,346,753 | 9.2% |
| SRRK | March 31, 2025 | 183,243 | $7,919,762 | 72.3% |
| TVTX | June 30, 2025 | 408,849 | $7,326,574 | 338.0% |
| COGT | March 31, 2025 | 921,137 | $7,184,869 | 505.3% |
| GILD | June 30, 2025 | 62,029 | $6,950,349 | 31.2% |
| GOSS | March 31, 2026 | 2,135,722 | $6,620,738 | -52.8% |
| HLXB | Sept. 30, 2025 | 613,393 | $6,514,234 | No longer tracked |
| LXEO | March 31, 2026 | 617,608 | $6,132,847 | -9.2% |
| AMLX | March 31, 2026 | 506,242 | $6,115,403 | 177.1% |
| MTSR | Sept. 30, 2025 | 207,581 | $5,905,679 | No longer tracked |
| CLDX | June 30, 2026 | 178,378 | $5,658,150 | 9.5% |
| SLNO | March 31, 2026 | 117,485 | $5,439,556 | No longer tracked |
| ALKS | Dec. 31, 2025 | 180,513 | $5,415,390 | 76.3% |
| BBOT | Dec. 31, 2025 | 457,414 | $5,296,854 | -23.4% |
| RARE | March 31, 2025 | 124,388 | $5,233,003 | -26.7% |
| OLMA | March 31, 2026 | 206,280 | $5,157,000 | -26.6% |
| CYTK | June 30, 2026 | 71,203 | $4,692,990 | -10.1% |
| CLYM | June 30, 2026 | 684,908 | $4,691,620 | 31.4% |
| PHVS | Dec. 31, 2025 | 183,903 | $4,588,380 | 31.6% |
| CMPX | June 30, 2026 | 859,049 | $4,544,369 | 11.9% |
| SRZN | June 30, 2026 | 144,255 | $4,202,148 | -8.1% |
| TARS | June 30, 2025 | 81,331 | $4,177,973 | 78.7% |
| ALKS | June 30, 2025 | 124,871 | $4,123,240 | 72.4% |
| OCUL | June 30, 2025 | 551,570 | $4,043,008 | 23.4% |
| BCAX | Dec. 31, 2025 | 250,606 | $3,957,069 | 49.8% |
| BBIO | June 30, 2025 | 111,000 | $3,837,270 | 92.8% |
| KURA | June 30, 2025 | 581,369 | $3,837,035 | 111.0% |
| GPCR | Sept. 30, 2025 | 175,636 | $3,642,691 | 90.2% |
| KNSA | Dec. 31, 2025 | 88,910 | $3,452,375 | 93.1% |
| MLYS | March 31, 2026 | 94,983 | $3,446,933 | -3.3% |
| MDGL | June 30, 2025 | 10,344 | $3,426,243 | 77.1% |
| INCY | March 31, 2025 | 49,000 | $3,384,430 | 111.6% |
| RLAY | March 31, 2026 | 398,167 | $3,368,493 | 99.9% |
| PCVX | March 31, 2025 | 40,788 | $3,338,906 | 63.1% |
| ZURA | June 30, 2026 | 560,651 | $3,335,873 | -3.1% |
| BPMC | June 30, 2025 | 37,345 | $3,305,406 | No longer tracked |
| EYPT | Dec. 31, 2025 | 230,837 | $3,287,119 | -68.9% |
| GERN | March 31, 2025 | 920,022 | $3,256,878 | -1.6% |
| FULC | June 30, 2026 | 419,949 | $3,221,009 | 5.7% |
| LQDA | June 30, 2025 | 214,057 | $3,157,341 | 485.1% |
| ZURA | Dec. 31, 2025 | 720,452 | $3,119,557 | 9.2% |
| PTCT | June 30, 2025 | 60,389 | $3,077,423 | 49.4% |
| QURE | March 31, 2026 | 126,047 | $3,016,305 | 193.0% |
| TARS | March 31, 2026 | 36,124 | $2,957,833 | 3.2% |
| ANNX | June 30, 2026 | 496,461 | $2,750,394 | -6.7% |
| KYMR | March 31, 2026 | 34,589 | $2,691,370 | 49.3% |
| MNPR | June 30, 2026 | 43,488 | $2,382,708 | 29.3% |
| DCTH | Dec. 31, 2025 | 203,386 | $2,186,400 | 68.2% |
| CRNX | Dec. 31, 2025 | 50,000 | $2,082,500 | 82.0% |
| CAMP | Dec. 31, 2025 | 653,594 | $1,960,782 | -27.1% |
| VRDN | March 31, 2025 | 100,000 | $1,917,000 | 79.2% |
| NXTC | June 30, 2026 | 176,057 | $1,880,289 | 306.3% |
| ORKA | Sept. 30, 2025 | 165,389 | $1,854,011 | 456.4% |
| TRML | Sept. 30, 2025 | 109,257 | $1,747,019 | No longer tracked |
| SLDB | June 30, 2025 | 452,239 | $1,673,284 | 90.7% |
| CTMX | March 31, 2026 | 385,974 | $1,644,249 | -25.5% |
| NMRA | June 30, 2026 | 818,156 | $1,595,404 | -6.5% |
| XFOR | March 31, 2026 | 357,387 | $1,429,548 | -1.6% |
| CCCC | June 30, 2025 | 882,300 | $1,411,680 | 180.5% |
| KALA | June 30, 2025 | 246,079 | $1,410,033 | -81.1% |
| UNCY | June 30, 2025 | 2,413,489 | $1,387,515 | 17.4% |
| OLMA | March 31, 2025 | 233,281 | $1,360,028 | 191.2% |
| EWTX | June 30, 2026 | 42,615 | $1,342,373 | 10.4% |
| ABVX | June 30, 2025 | 210,901 | $1,318,131 | 1437.8% |
| REPL | June 30, 2026 | 171,936 | $1,315,310 | 28.7% |
| DYN | Dec. 31, 2025 | 100,000 | $1,265,000 | 33.0% |
| IFRX | June 30, 2025 | 1,161,567 | $1,184,798 | 168.4% |
| LBRX | Dec. 31, 2025 | 70,000 | $1,105,300 | 117.0% |
| MRSN | Dec. 31, 2025 | 133,636 | $1,037,015 | No longer tracked |
| EYPT | March 31, 2025 | 121,274 | $903,491 | 4.9% |
| IMVT | Dec. 31, 2025 | 50,000 | $806,000 | 74.2% |
| RADX | June 30, 2026 | 187,406 | $805,846 | -42.0% |
| FDMT | March 31, 2026 | 100,000 | $750,000 | 68.7% |
| MODD | Dec. 31, 2025 | 639,531 | $447,544 | 902.7% |
| KPTIXXXX | March 31, 2025 | 595,990 | $403,068 | No longer tracked |
| BDSX | Dec. 31, 2025 | 49,607 | $374,533 | 278.2% |
| XENE | June 30, 2025 | 10,121 | $339,560 | 97.0% |
| AVDL | June 30, 2025 | 39,366 | $308,236 | No longer tracked |
| BDSXXXXX | Sept. 30, 2025 | 1,070,367 | $302,058 | No longer tracked |
| RAPP | March 31, 2026 | 9,659 | $293,054 | 55.4% |
| SGMT | Sept. 30, 2025 | 37,539 | $286,047 | 53.2% |
| VXRT | June 30, 2025 | 683,825 | $278,317 | No longer tracked |
| MBX | Dec. 31, 2025 | 15,000 | $262,500 | 111.4% |
| PALI | March 31, 2026 | 102,108 | $239,954 | 19.4% |
| BIOA | March 31, 2025 | 39,974 | $231,449 | 175.5% |
| ELVN | Dec. 31, 2025 | 10,675 | $218,517 | 276.2% |
| MLTX | Dec. 31, 2025 | 30,000 | $215,100 | 24.2% |
| AARD | June 30, 2026 | 33,684 | $126,989 | 16.8% |
| ARCT | Dec. 31, 2025 | 3,445 | $63,491 | 73.5% |
| NKTR | Dec. 31, 2025 | 365 | $20,769 | 76.9% |